Arvinas Inc has a consensus price target of $45.43 based on the ratings of 22 analysts. The high is $95 issued by Oppenheimer on August 9, 2023. The low is $12 issued by Morgan Stanley on March 13, 2025. The 3 most-recent analyst ratings were released by Truist Securities, HC Wainwright & Co., and HC Wainwright & Co. on April 9, 2025, April 7, 2025, and March 14, 2025, respectively. With an average price target of $61 between Truist Securities, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 705.81% upside for Arvinas Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/09/2025 | Buy Now | 177.41% | Truist Securities | Joon Lee75% | $65 → $21 | Maintains | Buy | Get Alert |
04/07/2025 | Buy Now | 970.01% | HC Wainwright & Co. | Andrew Fein53% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
03/14/2025 | Buy Now | 970.01% | HC Wainwright & Co. | Andrew Fein53% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
03/13/2025 | Buy Now | 58.52% | Morgan Stanley | Terence Flynn65% | $48 → $12 | Maintains | Equal-Weight | Get Alert |
03/13/2025 | Buy Now | 322.72% | Guggenheim | Michael Schmidt49% | $57 → $32 | Maintains | Buy | Get Alert |
03/12/2025 | Buy Now | 243.46% | Wells Fargo | Derek Archila57% | $60 → $26 | Maintains | Overweight | Get Alert |
03/12/2025 | Buy Now | 164.2% | BMO Capital | Etzer Darout44% | $82 → $20 | Maintains | Outperform | Get Alert |
03/12/2025 | Buy Now | 58.52% | Wedbush | Robert Driscoll43% | $57 → $12 | Downgrade | Outperform → Neutral | Get Alert |
03/12/2025 | Buy Now | 269.88% | B of A Securities | Tazeen Ahmad55% | $54 → $28 | Maintains | Buy | Get Alert |
03/11/2025 | Buy Now | 970.01% | HC Wainwright & Co. | Andrew Fein53% | $81 → $81 | Reiterates | Buy → Buy | Get Alert |
03/07/2025 | Buy Now | 150.99% | Citigroup | Yigal Nochomovitz54% | $28 → $19 | Maintains | Neutral | Get Alert |
02/12/2025 | Buy Now | 494.45% | Oppenheimer | Matthew Biegler36% | $40 → $45 | Maintains | Outperform | Get Alert |
02/12/2025 | Buy Now | 983.22% | BMO Capital | Etzer Darout44% | $88 → $82 | Reiterates | Outperform → Outperform | Get Alert |
02/12/2025 | Buy Now | 652.97% | Guggenheim | Michael Schmidt49% | $57 → $57 | Reiterates | Buy → Buy | Get Alert |
02/12/2025 | Buy Now | 573.71% | Stifel | Bradley Canino39% | $63 → $51 | Maintains | Buy | Get Alert |
02/07/2025 | Buy Now | — | Cantor Fitzgerald | Li Watsek39% | — | Reiterates | Overweight → Overweight | Get Alert |
02/03/2025 | Buy Now | 322.72% | Barclays | Peter Lawson41% | $48 → $32 | Maintains | Overweight | Get Alert |
12/12/2024 | Buy Now | — | Guggenheim | Michael Schmidt49% | — | Reiterates | Buy → Buy | Get Alert |
12/11/2024 | Buy Now | 1049.27% | HC Wainwright & Co. | Andrew Fein53% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
11/20/2024 | Buy Now | 1062.48% | BMO Capital | Etzer Darout44% | $90 → $88 | Maintains | Outperform | Get Alert |
11/18/2024 | Buy Now | 626.55% | Stephens & Co. | Sudan Loganathan25% | → $55 | Initiates | → Overweight | Get Alert |
10/31/2024 | Buy Now | 1049.27% | HC Wainwright & Co. | Andrew Fein53% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
10/31/2024 | Buy Now | 428.4% | Oppenheimer | Matthew Biegler36% | $50 → $40 | Maintains | Outperform | Get Alert |
09/09/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek39% | — | Reiterates | → Overweight | Get Alert |
08/01/2024 | Buy Now | 1049.27% | HC Wainwright & Co. | Andrew Fein53% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
07/31/2024 | Buy Now | 652.97% | Wedbush | Robert Driscoll43% | $57 → $57 | Reiterates | Outperform → Outperform | Get Alert |
07/31/2024 | Buy Now | — | Cantor Fitzgerald | Li Watsek39% | — | Reiterates | → Overweight | Get Alert |
07/31/2024 | Buy Now | 534.08% | Barclays | Peter Lawson41% | $60 → $48 | Maintains | Overweight | Get Alert |
07/31/2024 | Buy Now | 560.5% | Oppenheimer | Matthew Biegler36% | $70 → $50 | Maintains | Outperform | Get Alert |
05/17/2024 | Buy Now | 1049.27% | HC Wainwright & Co. | Andrew Fein53% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
05/09/2024 | Buy Now | 692.6% | Wells Fargo | Derek Archila57% | $63 → $60 | Maintains | Overweight | Get Alert |
05/08/2024 | Buy Now | 652.97% | Wedbush | Robert Driscoll43% | $57 → $52 | Reiterates | Outperform → Outperform | Get Alert |
05/08/2024 | Buy Now | 1049.27% | HC Wainwright & Co. | Andrew Fein53% | $87 → $87 | Reiterates | Buy → Buy | Get Alert |
05/08/2024 | Buy Now | 798.28% | Stifel | Bradley Canino39% | $72 → $68 | Maintains | Buy | Get Alert |
04/15/2024 | Buy Now | 1049.27% | HC Wainwright & Co. | Andrew Fein53% | $90 → $87 | Maintains | Buy | Get Alert |
04/12/2024 | Buy Now | 1049.27% | HC Wainwright & Co. | Andrew Fein53% | $90 → $87 | Maintains | Buy | Get Alert |
03/25/2024 | Buy Now | 758.65% | Truist Securities | Joon Lee75% | → $65 | Reiterates | Buy → Buy | Get Alert |
02/29/2024 | Buy Now | 692.6% | Barclays | Peter Lawson41% | $26 → $60 | Maintains | Overweight | Get Alert |
02/28/2024 | Buy Now | 1088.9% | HC Wainwright & Co. | Andrew Fein53% | $90 → $90 | Reiterates | Buy → Buy | Get Alert |
02/28/2024 | Buy Now | 1088.9% | BMO Capital | Etzer Darout44% | $89 → $90 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | 679.39% | Wedbush | Robert Driscoll43% | $33 → $59 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | 956.8% | Oppenheimer | Matthew Biegler36% | $95 → $80 | Reiterates | Outperform → Outperform | Get Alert |
02/15/2024 | Buy Now | 626.55% | Citigroup | Yigal Nochomovitz54% | $36 → $55 | Downgrade | Buy → Neutral | Get Alert |
02/14/2024 | Buy Now | 626.55% | Citigroup | Yigal Nochomovitz54% | $36 → $55 | Downgrade | Buy → Neutral | Get Alert |
02/01/2024 | Buy Now | 824.7% | Goldman Sachs | Paul Choi60% | → $70 | Initiates | → Buy | Get Alert |
12/19/2023 | Buy Now | 732.23% | Wells Fargo | Derek Archila57% | → $63 | Upgrade | Equal-Weight → Overweight | Get Alert |
12/06/2023 | Buy Now | 428.4% | Jefferies | Akash Tewari43% | $32 → $40 | Upgrade | Hold → Buy | Get Alert |
11/20/2023 | Buy Now | 428.4% | Guggenheim | Michael Schmitz42% | → $40 | Upgrade | Neutral → Buy | Get Alert |
11/13/2023 | Buy Now | 164.2% | Morgan Stanley | Terence Flynn65% | $32 → $20 | Maintains | Equal-Weight | Get Alert |
11/08/2023 | Buy Now | 454.82% | Stifel | Bradley Canino39% | $46 → $42 | Maintains | Buy | Get Alert |
10/24/2023 | Buy Now | 375.56% | Citigroup | Yigal Nochomovitz54% | $72 → $36 | Maintains | Buy | Get Alert |
10/24/2023 | Buy Now | 243.46% | Barclays | Peter Lawson41% | $39 → $26 | Maintains | Overweight | Get Alert |
10/23/2023 | Buy Now | 626.55% | Piper Sandler | Edward Tenthoff51% | $70 → $55 | Maintains | Overweight | Get Alert |
10/23/2023 | Buy Now | 217.04% | Wedbush | Robert Driscoll43% | $27 → $24 | Upgrade | Neutral → Outperform | Get Alert |
09/07/2023 | Buy Now | 824.7% | Cantor Fitzgerald | Li Watsek39% | → $70 | Reiterates | Overweight → Overweight | Get Alert |
08/21/2023 | Buy Now | 851.12% | Citigroup | Yigal Nochomovitz54% | $77 → $72 | Maintains | Buy | Get Alert |
08/16/2023 | Buy Now | 758.65% | Truist Securities | Joon Lee75% | → $65 | Reiterates | Buy → Buy | Get Alert |
08/14/2023 | Buy Now | 322.72% | Morgan Stanley | Terence Flynn65% | $35 → $32 | Maintains | Equal-Weight | Get Alert |
08/09/2023 | Buy Now | 1154.95% | Oppenheimer | Mark Breidenbach48% | → $95 | Reiterates | Outperform → Outperform | Get Alert |
08/09/2023 | Buy Now | 415.19% | Barclays | Peter Lawson41% | $70 → $39 | Maintains | Overweight | Get Alert |
08/09/2023 | Buy Now | 1088.9% | HC Wainwright & Co. | Andrew Fein53% | → $90 | Reiterates | Buy → Buy | Get Alert |
06/26/2023 | Buy Now | 1154.95% | Oppenheimer | Mark Breidenbach48% | → $95 | Assumes | → Outperform | Get Alert |
06/09/2023 | Buy Now | 256.67% | Wedbush | Robert Driscoll43% | → $27 | Reiterates | Neutral → Neutral | Get Alert |
06/09/2023 | Buy Now | 1088.9% | HC Wainwright & Co. | Andrew Fein53% | → $90 | Reiterates | Buy → Buy | Get Alert |
05/12/2023 | Buy Now | 362.35% | Morgan Stanley | Terence Flynn65% | $38 → $35 | Maintains | Equal-Weight | Get Alert |
05/08/2023 | Buy Now | 1154.95% | Oppenheimer | Mark Breidenbach48% | → $95 | Reiterates | → Outperform | Get Alert |
05/08/2023 | Buy Now | 705.81% | Credit Suisse | Richard Law42% | → $61 | Reiterates | → Outperform | Get Alert |
05/08/2023 | Buy Now | 851.12% | Stifel | Bradley Canino39% | $75 → $72 | Maintains | Buy | Get Alert |
05/08/2023 | Buy Now | 1088.9% | HC Wainwright & Co. | Andrew Fein53% | → $90 | Reiterates | → Buy | Get Alert |
02/27/2023 | Buy Now | 375.56% | Morgan Stanley | Terence Flynn65% | $57 → $36 | Maintains | Equal-Weight | Get Alert |
02/24/2023 | Buy Now | 705.81% | Credit Suisse | Richard Law42% | $81 → $61 | Maintains | Outperform | Get Alert |
02/24/2023 | Buy Now | 1088.9% | HC Wainwright & Co. | Andrew Fein53% | → $90 | Reiterates | → Buy | Get Alert |
01/31/2023 | Buy Now | 1088.9% | Cantor Fitzgerald | Li Watsek39% | → $90 | Reiterates | → Overweight | Get Alert |
01/17/2023 | Buy Now | 758.65% | Truist Securities | Joon Lee75% | $100 → $65 | Maintains | Buy | Get Alert |
01/12/2023 | Buy Now | — | Guggenheim | Michael Schmidt49% | — | Downgrade | Buy → Neutral | Get Alert |
01/03/2023 | Buy Now | 547.29% | Wells Fargo | Derek Archila57% | $83 → $49 | Downgrade | Overweight → Equal-Weight | Get Alert |
12/05/2022 | Buy Now | 851.12% | Citigroup | Yigal Nochomovitz54% | $88 → $72 | Maintains | Buy | Get Alert |
11/23/2022 | Buy Now | 824.7% | Barclays | Peter Lawson41% | $90 → $70 | Maintains | Overweight | Get Alert |
11/23/2022 | Buy Now | 970.01% | Piper Sandler | Edward Tenthoff51% | $76 → $81 | Maintains | Overweight | Get Alert |
11/23/2022 | Buy Now | 824.7% | SVB Leerink | Andrew Berens49% | $74 → $70 | Maintains | Outperform | Get Alert |
11/22/2022 | Buy Now | 877.54% | SVB Leerink | Andrew Berens49% | $89 → $74 | Maintains | Outperform | Get Alert |
11/11/2022 | Buy Now | 652.97% | Morgan Stanley | Terence Flynn65% | $63 → $57 | Maintains | Equal-Weight | Get Alert |
09/09/2022 | Buy Now | 1088.9% | Barclays | Peter Lawson41% | → $90 | Initiates | → Overweight | Get Alert |
08/08/2022 | Buy Now | 1247.42% | Oppenheimer | Mark Breidenbach48% | $108 → $102 | Maintains | Outperform | Get Alert |
08/05/2022 | Buy Now | 1075.69% | SVB Leerink | Andrew Berens49% | $91 → $89 | Maintains | Outperform | Get Alert |
08/05/2022 | Buy Now | 1088.9% | HC Wainwright & Co. | Andrew Fein53% | $135 → $90 | Maintains | Buy | Get Alert |
08/05/2022 | Buy Now | 930.38% | Credit Suisse | Richard Law42% | $98 → $78 | Maintains | Outperform | Get Alert |
06/21/2022 | Buy Now | 454.82% | Jefferies | Akash Tewari43% | → $42 | Initiates | → Hold | Get Alert |
05/24/2022 | Buy Now | 1075.69% | Goldman Sachs | Madhu Kumar72% | $111 → $89 | Maintains | Buy | Get Alert |
05/23/2022 | Buy Now | 903.96% | Piper Sandler | Edward Tenthoff51% | $116 → $76 | Maintains | Overweight | Get Alert |
05/20/2022 | Buy Now | 1260.63% | Citigroup | Yigal Nochomovitz54% | $113 → $103 | Maintains | Buy | Get Alert |
05/09/2022 | Buy Now | 745.44% | Morgan Stanley | Terence Flynn65% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
05/09/2022 | Buy Now | — | Wedbush | Robert Driscoll43% | — | Downgrade | Outperform → Neutral | Get Alert |
04/28/2022 | Buy Now | 1273.84% | Credit Suisse | Richard Law42% | → $104 | Initiates | → Outperform | Get Alert |
The latest price target for Arvinas (NASDAQ:ARVN) was reported by Truist Securities on April 9, 2025. The analyst firm set a price target for $21.00 expecting ARVN to rise to within 12 months (a possible 177.41% upside). 34 analyst firms have reported ratings in the last year.
The latest analyst rating for Arvinas (NASDAQ:ARVN) was provided by Truist Securities, and Arvinas maintained their buy rating.
The last upgrade for Arvinas Inc happened on December 19, 2023 when Wells Fargo raised their price target to $63. Wells Fargo previously had an equal-weight for Arvinas Inc.
The last downgrade for Arvinas Inc happened on March 12, 2025 when Wedbush changed their price target from $57 to $12 for Arvinas Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Arvinas, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Arvinas was filed on April 9, 2025 so you should expect the next rating to be made available sometime around April 9, 2026.
While ratings are subjective and will change, the latest Arvinas (ARVN) rating was a maintained with a price target of $65.00 to $21.00. The current price Arvinas (ARVN) is trading at is $7.57, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.